Long Acting Injections and Implants

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Advances in Delivery Science and Technology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-1-4614-0554-2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics.

  2010cited by this paper
• Preparation and characterization of collagen microspheres for sustained release of VEGF

  2010cited by this paper
• Albumin/gentamicin microspheres produced by supercritical assisted atomization: optimization of size, drug loading and release.

  2010cited by this paper
• Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers.

  2010cited by this paper
• Folate-mediated solid–liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol)

  2010cited by this paper
• Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery.

  2010cited by this paper
• Preparation and surface characterization of poly-L-lysine-coated PLGA microsphere scaffolds containing retinoic acid for nerve tissue engineering: in vitro study.

  2009cited by this paper
• Synthesis and Evaluation of Pegylated Dendrimeric Nanocarrier for Pulmonary Delivery of Low Molecular Weight Heparin

  2009cited by this paper
• Molecular dynamics study of the structure and interparticle interactions of polyethylene glycol-conjugated PAMAM dendrimers.

  2009cited by this paper
• Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.

  2009cited by this paper
• Oligoarginine-PEG-lipid particles for gene delivery

  2009cited by this paper
• Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging.

  2009cited by this paper
• Preparation and evaluation of PEG-PCL nanoparticles for local tetradrine delivery.

  2009cited by this paper
• Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimers.

  2009cited by this paper
• Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers.

  2009cited by this paper
• Quantification and reactivity of functional groups in the ligand shell of PEGylated gold nanoparticles via a fluorescence-based assay.

  2009cited by this paper
• Functional single-walled carbon nanotubes based on an integrin αvβ3 monoclonal antibody for highly efficient cancer cell targeting

  2009cited by this paper
• Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.

  2009cited by this paper
• PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats.

  2009cited by this paper
• Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: implications for oral drug delivery.

  2009cited by this paper
• Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery.

  2009cited by this paper
• Tumor cell targeting using folate-conjugated fluorescent quantum dots and receptor-mediated endocytosis.

  2009cited by this paper
• Preparation of carbon nanotube bioconjugates for biomedical applications

  2009cited by this paper
• Critical parameters in the pegylation of gold nanoshells for biomedical applications: An in vitro macrophage study

  2009cited by this paper
• Characterization of PLGA nanospheres stabilized with amphiphilic polymers: hydrophobically modified hydroxyethyl starch vs pluronics.

  2009cited by this paper
• Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.

  2009cited by this paper
• Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas.

  2009cited by this paper
• Water-soluble metal nanoparticles with PEG-tagged 15-membered azamacrocycles as stabilizers.

  2009cited by this paper
• Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery.

  2009cited by this paper
• Nuclear penetration of surface functionalized gold nanoparticles.

  2009cited by this paper
• Multifunctional ligands based on dihydrolipoic acid and polyethylene glycol to promote biocompatibility of quantum dots

  2009cited by this paper
• Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes.

  2009cited by this paper
• Influence of PEG chain on the complement activation suppression and longevity in vivo prolongation of the PCL biomedical nanoparticles

  2009cited by this paper
• Colloidal dispersions of monodisperse magnetite nanoparticles modified with poly(ethylene glycol).

  2009cited by this paper
• Treatment of Experimental Arthritis with Stealth-Type Polymeric Nanoparticles Encapsulating Betamethasone Phosphate

  2009cited by this paper
• In vitro performance of an injectable hydrogel/microsphere based immunocyte delivery system for localised anti-tumour activity.

  2009cited by this paper
• Effect of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles.

  2009cited by this paper
• Self-Healing Polymers Microencapsulate Biomacromolecules without Organic Solvents.

  2009cited by this paper
• PEGylation strategies for active targeting of PLA/PLGA nanoparticles.

  2009cited by this paper
• Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.

  2009cited by this paper
• Oxidative stress and inflammatory response in dermal toxicity of single-walled carbon nanotubes.

  2009cited by this paper
• Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations.

  2009cited by this paper
• The decrease of PAMAM dendrimer-induced cytotoxicity by PEGylation via attenuation of oxidative stress

  2009cited by this paper
• Effect of poly(ethylene glycol) length on the in vivo behavior of coated quantum dots.

  2009cited by this paper
• Partly-PEGylated Poly-L-lysine dendrimers have reduced plasma stability and circulation times compared with fully PEGylated dendrimers.

  2009cited by this paper
• Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody

  2009cited by this paper
• PEG-conjugated PAMAM Dendrimers Mediate Efficient Intramuscular Gene Expression

  2009cited by this paper
• Nanosized cancer cell-targeted polymeric immunomicelles loaded with superparamagnetic iron oxide nanoparticles

  2009cited by this paper
• Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction.

  2009cited by this paper
• Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.

  2009cited by this paper
• Reversible accumulation of PEGylated single-walled carbon nanotubes in the mammalian nucleus.

  2008cited by this paper
• Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.

  2008cited by this paper
• Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity.

  2008cited by this paper
• PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue.

  2008cited by this paper
• Controlling the reactivity of ampiphilic quantum dots in biological assays through hydrophobic assembly of custom PEG derivatives.

  2008cited by this paper
• Efficacy of bone regeneration using collagen microspheres as scaffold

  2008cited by this paper
• Analysis of initial burst in PLGA microparticles.

  2008cited by this paper
• PEG-grafted chitosan nanoparticles as an injectable carrier for sustained protein release

  2008cited by this paper
• Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate.

  2008cited by this paper
• Preparation of poly(ethylene glycol) protected nanoparticles with variable bioconjugate ligand density.

  2008cited by this paper
• Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats.

  2008cited by this paper
• Microencapsulation by solvent evaporation: state of the art for process engineering approaches.

  2008cited by this paper
• Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device.

  2008cited by this paper
• The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers.

  2008cited by this paper
• The origins and evolution of "controlled" drug delivery systems.

  2008cited by this paper
• Completely dispersible PEGylated gold nanoparticles under physiological conditions: modification of gold nanoparticles with precisely controlled PEG-b-polyamine.

  2008cited by this paper
• Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin.

  2008cited by this paper
• Cell-type specific and cytoplasmic targeting of PEGylated carbon nanotube-based nanoassemblies.

  2008cited by this paper
• Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery.

  2008cited by this paper
• Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy.

  2008cited by this paper
• The role of the size and number of polyethylene glycol chains in the biodistribution and tumor localization of triazine dendrimers.

  2008cited by this paper
• Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy

  2008cited by this paper
• VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis.

  2008cited by this paper
• Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone

  2008cited by this paper
• Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro.

  2008cited by this paper
• Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.

  2008cited by this paper
• Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice.

  2008cited by this paper
• Preparation and characterization of magnetic poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) microspheres.

  2008cited by this paper
• Functionalized Solid Lipid Nanoparticles for Transendothelial Delivery

  2008cited by this paper
• Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles.

  2008cited by this paper
• Stealth dendrimers for drug delivery: correlation between PEGylation, cytocompatibility, and drug payload

  2008cited by this paper
• PR_b-targeted PEGylated liposomes for prostate cancer therapy.

  2008cited by this paper
• How to very efficiently functionalize gold nanoparticles by "click" chemistry.

  2008cited by this paper
• PEG-ylated cationic CdSe/ZnS QDs as an efficient intracellular labeling agent.

  2008cited by this paper
• Polymeric protein delivery systems

  2007cited by this paper
• Effect of Cationic Liposome Formulation on Human Carcinoma Hepatic SMMC-7721 Cells' Uptake of Tenofovir and Cytotoxicity

  2007cited by this paper
• Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis.

  2007cited by this paper
• Preparation of poly(ethylene glycol)-attached dendrimers encapsulating photosensitizers for application to photodynamic therapy.

  2007cited by this paper
• Preparation of poly(ethylene glycol)-modified poly(amido amine) dendrimers encapsulating gold nanoparticles and their heat-generating ability.

  2007cited by this paper
• The effect of cross-linking of chitosan microspheres with genipin on protein release

  2007cited by this paper
• Effect of acidic pH on PLGA microsphere degradation and release.

  2007cited by this paper
• Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging.

  2007cited by this paper
• Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers.

  2007cited by this paper
• Stealth dendrimers for antiarrhythmic quinidine delivery

  2007cited by this paper
• Spray drying conditions and encapsulating composition effects on formation and properties of sodium diclofenac microparticles

  2007cited by this paper
• PEG-modified gold nanorods with a stealth character for in vivo applications.

  2006cited by this paper
• Elevated temperature accelerated release testing of PLGA microspheres.

  2006cited by this paper
• Adriamycin release from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization

  2006cited by this paper
• Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery.

  2006cited by this paper
• Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.

  2006cited by this paper

• Using PBPK to Simulate Target Biopredictive Dissolution Profiles for Long-Acting Injectables - Where to Begin With Critical Bioavailability Attributes?

  2026cites this paper
• Advances in Long-Acting Injectable Drug Delivery: Formulation Science, Emerging Technologies, and Future Perspectives

  2025cites this paper
• Gellan gum formulations containing natural polyphenolic compounds to treat oral candidiasis

  2025cites this paper
• The Impact of a Manufacturing Process on the Stability of Microcrystalline Long-Acting Injections: A Case Study on Aripiprazole Monohydrate

  2025cites this paper
• Injectable PLGA-based In Situ Forming Subconjunctival Implant for Sustained Ocular Delivery of Ketotifen Fumarate: Formulation, Drug Release, and Biocompatibility Studies

  2025cites this paper
• Unveiling the Future: Opportunities in Long-Acting Injectable Drug Development for Veterinary Care

  2025cites this paper
• PLGA-based long-acting injectable (LAI) formulations.

  2025cites this paper
• Particle size matters: The impact of particle size on properties and performance of long-acting injectable crystalline aqueous suspensions.

  2025cites this paper
• Long-acting parenteral formulations of hydrophilic drugs, proteins, and peptide therapeutics: mechanisms, challenges, and therapeutic benefits with a focus on technologies

  2024cites this paper
• Polymer Delivery Systems for Long-Acting Antiretroviral Drugs

  2024cites this paper
• Effect of polycation coating on the long-term pulsatile release of antigenic ESAT-61-20 peptide from PLGA nanoparticles.

  2023cites this paper
• Long-Acting Injectable Antipsychotics—A Review on Formulation and In Vitro Dissolution

  2023cites this paper
• Recent advances in dosage form design for the elderly: a review

  2023cites this paper
• Recent Advances in Long-Acting Drug Delivery and Formulations

  2023cites this paper
• Comprehensive Assessment of Transcorneal Permeation, Antimicrobial, and Antifungal Activities of Andrographolide-Loaded Nanosuspension: In vitro and In vivo Studies

  2023cites this paper
• Advances in drug delivery systems, challenges and future directions

  2023cites this paper
• Recent advances in lipid-based long-acting injectable depot formulations.

  2023cites this paper
• Delivering on the promise of protein degraders

  2023cites this paper
• Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working Group

  2023cites this paper
• Controlled delivery via hot-melt extrusion: A focus on non-biodegradable carriers for non-oral applications

  2023cites this paper
• Preparation and characterization of morphine gelatine microspheres

  2022cites this paper
• Continuous Processing of Micropellets via Hot-Melt Extrusion

  2022cites this paper
• Curcumin-Loaded Liposome Preparation in Ultrasound Environment under Pressurized Carbon Dioxide

  2022cites this paper
• Clinical translation of long-acting drug delivery formulations

  2022cites this paper
• Efficient aqueous remote loading of peptides in poly(lactic-co-glycolic acid)

  2021cites this paper
• Linking In Vitro Intrinsic Dissolution Rate and Thermodynamic Solubility with Pharmacokinetic Profiles of Bedaquiline Long-Acting Aqueous Microsuspensions in Rats.

  2021cites this paper
• Nanocrystallization and Nanoprecipitation Technologies

  2021cites this paper
• Multiparametric magnetic resonance imaging to characterize cabotegravir long‐acting formulation depot kinetics in healthy adult volunteers

  2021cites this paper
• Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs

  2020cites this paper
• Preparation and characterization of 12-HSA-based organogels as injectable implants for the controlled delivery of hydrophilic and lipophilic therapeutic agents.

  2020cites this paper
• Microneedle array systems for long-acting drug delivery.

  2020cites this paper
• Preparation of liposomes encapsulating β–carotene using supercritical carbon dioxide with ultrasonication

  2020cites this paper
• Tuning HIV drug release from a nanogel-based in situ forming implant by changing nanogel size.

  2019cites this paper
• A radical containing injectable in‐situ‐oleogel and emulgel for prolonged in‐vivo oxygen measurements with CW EPR

  2019cites this paper
• Development and Characterization of Olanzapine Loaded Poly(lactide-coglycolide) Microspheres for Depot Injection: In vitro and In vivo Release Profiles.

  2019cites this paper
• Influence of drying processes on the structures, morphology and in vitro release profiles of risperidone-loaded PLGA microspheres

  2019cites this paper
• Development and evaluation of intramuscularly administered nano/microcrystal suspension

  2019cites this paper
• Effect of minor manufacturing changes on stability of compositionally equivalent PLGA microspheres.

  2019cites this paper
• ELQ-331 as a prototype for extremely durable chemoprotection against malaria

  2019cites this paper
• Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery

  2019cites this paper
• EVOLUTION OF CONTRACEPTIVE IMPLANTS: A REVIEW

  2018cites this paper
• Controlling release from 3D printed medical devices using CLIP and drug‐loaded liquid resins

  2018cites this paper
• Delivery of radix ophiopogonis polysaccharide via sucrose acetate isobutyrate-based in situ forming systems alone or combined with its mono-PEGylation

  2018cites this paper
• Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications

  2018cites this paper
• Biological role and therapeutic potential of phytoflavonoids and vitamin D in the treatment of patients with uterine myoma, as well as other promising pharmacological directions

  2018cites this paper
• Drug delivery systems for programmed and on‐demand release☆

  2018cites this paper
• Non-invasive delivery strategies for biologics

  2018cites this paper
• A method of elevated temperatures coupled with magnetic stirring to predict real time release from long acting progesterone PLGA microspheres

  2018cites this paper
• Pharmaceutical Amorphous Nanoparticles.

  2017cites this paper
• Hydrophobic mixed solvent induced PLGA-based in situ forming systems for smooth long-lasting delivery of Radix Ophiopogonis polysaccharide in rats

  2017cites this paper
• Clinically advancing and promising polymer-based therapeutics.

  2017influential citation
• Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial

  2017cites this paper
• Dual-stimuli responsive injectable microgel/solid drug nanoparticle nanocomposites for release of poorly soluble drugs.

  2017cites this paper
• Multimodal imaging approach to examine biodistribution kinetics of Cabotegravir (GSK1265744) long acting parenteral formulation in rat

  2017cites this paper
• Characterization of a Liquid Crystal System for Sustained Release of a Peptide BMS-686117

  2017cites this paper
• University of Groningen Innovative platform technologies for stabilization and controlled release of proteins from polymer depots

  2017cites this paper
• Formulations d'olanzapine à libération prolongée

  2016cites this paper
• Scale-up from batch to flow-through wet milling process for injectable depot formulation.

  2016cites this paper
• Development of biodegradable implants with specific drug release profiles

  2016cites this paper
• Design of block-copolymer-based micelles for active and passive targeting.

  2016cites this paper
• VOITTO KÄNKÄNEN OPTIMIZATION OF SILICONE ELASTOMER FORMULATIONS FOR TWO CONTROLLED RELEASE DRUG DELIVERY

  2015cites this paper
• Nanosuspension: An Emerging Trend for Bioavailability Enhancement of Etodolac

  2015cites this paper
• Preparation of SLN-containing Thermoresponsive In-situ Forming Gel as a Controlled Nanoparticle Delivery System and Investigating its Rheological, Thermal and Erosion Behavior

  2015cites this paper
• Polymeric formulations for drug release prepared by hot melt extrusion: application and characterization.

  2015cites this paper
• Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition.

  2015cites this paper
• Delivery of long-acting injectable antivirals: best approaches and recent advances

  2015cites this paper
• Novel Nrf2 activators from microbial transformation products inhibit blood–retinal barrier permeability in rabbits

  2015cites this paper
• Fabricating Superhydrophobic Polymeric Materials for Biomedical Applications.

  2015cites this paper
• Responsive foams for nanoparticle delivery.

  2015cites this paper
• Nanotechnology Applications in Local Arterial Drug Delivery

  2014cites this paper
• Spray Dried Nano-Crystalline Powders and In Vitro Dissolution Performance

  2014cites this paper
• Long-Acting Atypical Antipsychotics: Characterization of the Local Tissue Response

  2014cites this paper
• Prodrugs of pioglitazone for extended-release (XR) injectable formulations.

  2014cites this paper
• An overview of clinical and commercial impact of drug delivery systems.

  2014cites this paper
• Development of a Poly (lactic-co-glycolic acid) Particle Vaccine to Protect Against House Dust Mite Induced Allergy

  2014cites this paper
• Innovative platform technologies for stabilization and controlled release of proteins from polymer depots

  2014cites this paper
• Innovative platform technologies for stabilization and controlled release of proteins from polymer depots

  2014cites this paper
• Formulation and Performance of Danazol Nano-crystalline Suspensions and Spray Dried Powders

  2014cites this paper
• Imparting Superhydrophobicity to Biodegradable Poly(lactide-co-glycolide) Electrospun Meshes

  2014cites this paper
• Non-eroding drug-releasing implants with ordered nanoporous and nanotubular structures: concepts for controlling drug release.

  2014cites this paper
• Tailored protein release from biodegradable poly(ε-caprolactone-PEG)-b-poly(ε-caprolactone) multiblock-copolymer implants.

  2014cites this paper
• Injectable long-acting systems for Radix Ophiopogonis polysaccharide based on mono-PEGylation and in situ formation of a PLGA depot

  2014influential citation
• Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

  2014cites this paper
• Development of an oily sustained release depot formulation in a prefilled syringe

  2013cites this paper
• Virgin Coconut Oil Containing Injectable Vehicles for Ibuprofen Sustainable Release

  2013cites this paper
• Polymeric drugs for controlled release of analgesics

  2013cites this paper
• In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges

  2013cites this paper
• PREFILLED SYRINGES FOR VISCOUS FORMULATIONS

  2013cites this paper
• Current state and developmental prospects for nanopatterned implants containing drugs

  2013cites this paper
• Nanocrystal formulation for poorly soluble drugs

  2013cites this paper
• Delivering drugs to farmed animals using controlled release science and technology

  2012influential citation
• A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes.

  2012cites this paper